06.01.23 -- Not All Plate Counting Technologies Are The Same
06/01/23 Pharmaceutical Online Newsletter
Source: pharmaceuticalonline.com
📰 Case Study Dec Group News
Case Study Dec Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Case Study Dec Group. Real-time updates on events, politics, business and more.
10.21.22 -- Pharma 4.0 Software Methodologies In Biopharma
10/21/22 Pharmaceutical Online Newsletter
Source: pharmaceuticalonline.com
06.09.22 -- Essential Components Of A Sterility Assurance Program
06/09/22 Pharmaceutical Online Newsletter
Matthew Minakowski Webinar Samsung Biologics Webinar Lonza Webinar Cytiva Webinar Catalent Harry Berlanga
Source: pharmaceuticalonline.com
02.03.22 -- Troubleshooting A Failed Process Performance Qualification: Lessons Learned
02/03/22 Pharmaceutical Online Newsletter
Source: pharmaceuticalonline.com
01.20.22 -- US Congress Passes Bill Supporting New Era of Biopharma Advanced & Continuous Manufacturing
01/20/22 Pharmaceutical Online Newsletter
Source: pharmaceuticalonline.com
12.10.21 -- Regulatory Intelligence: More Than Just Compliance
12/10/21 Pharmaceutical Online Newsletter
Source: pharmaceuticalonline.com
12.02.21 -- Model-Based Control In Continuous Manufacturing Of Biotherapeutics: The Role Of Process Integration
12/02/21 Pharmaceutical Online Newsletter
Source: pharmaceuticalonline.com
01.26.21 -- Top 10 Most-Cited MHRA GMP Inspection Deficiencies
01.26.21 -- Top 10 Most-Cited MHRA GMP Inspection Deficiencies Continuing our Cell & Gene series, Business of Biotech features Dr. Bobby Gaspar, Orchard Therapeutics CEO, speaking on the challenges his company faces in the production of hematopoietic stem cells to treat neurometabolic disorders, primary immune deficiencies, and blood disorders. Listen now and subscribe so you never miss an episode. Featured Editorial By Barbara Unger, Unger Consulting Inc. ...
Russian Federation Colins Sinclair Webinar Coperion Coperionk Tron Ken Langhorn John Ward Vladimir Putin
Source: pharmaceuticalonline.com
12.17.20 -- FDA FY2020 Drug Inspection Observations And Trends
12.17.20 -- FDA FY2020 Drug Inspection Observations And Trends ISR’s Health Panel includes managers, directors, executives, and subject matter experts in clinical development and drug manufacturing who work at pharma companies, service provider companies, and research sites. Members are paid for their time (a 15-minute survey may pay $40, whereas a 45-minute phone interview may pay $150) and they get to choose which research opportunities to participate i...
Source: pharmaceuticalonline.com